Publication | Closed Access
Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study
229
Citations
28
References
2019
Year
Neuro-oncologyLymphoid NeoplasiaMedicineHovon 105/AllgImmunologyPrimary Cns LymphomaPathologyIntergroup StudyLymphatic DiseaseOncologyRadiation OncologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1